乳房切除术后放疗的当前适应症。
Current indications for post-mastectomy radiation.
作者信息
Vilarino-Varela Maria, Chin Yaw Sinn, Makris Andreas
机构信息
Academic Oncology Unit, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, HA6 2RN, UK.
出版信息
Int Semin Surg Oncol. 2009 Feb 9;6:5. doi: 10.1186/1477-7800-6-5.
Abstract
It has been long established that post-mastectomy radiotherapy reduces the risk of locoregional failure. A survival advantage, however, has only recently been demonstrated. We here provide a review of the literature as regards to the current indications for post-mastectomy radiotherapy.
摘要
长期以来，乳房切除术后放疗可降低局部区域复发风险已得到证实。然而，生存获益直到最近才得到证实。我们在此就乳房切除术后放疗的当前适应证对文献进行综述。
相似文献
1
Current indications for post-mastectomy radiation.乳房切除术后放疗的当前适应症。
Int Semin Surg Oncol. 2009 Feb 9;6:5. doi: 10.1186/1477-7800-6-5.
2
Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review.对于早期、无淋巴结转移的乳腺癌年轻女性患者，乳房切除术后是否需要进行放疗？一项多机构回顾性研究。
Breast J. 2018 Jan;24(1):7-11. doi: 10.1111/tbj.12827. Epub 2017 Jun 7.
3
Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer.中国绝经前和绝经后乳腺癌女性术后局部区域放疗的临床结局
Radiother Oncol. 2000 Mar;54(3):201-8. doi: 10.1016/s0167-8140(99)00176-0.
4
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.炎性乳腺癌的局部区域放疗：剂量递增在降低复发方面的有效性
Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1191-200. doi: 10.1016/s0360-3016(00)00561-7.
5
[Radiation therapy after mastectomy--interdisciplinary consensus puts and end to a controversy. German Society of Senology].乳房切除术后的放射治疗——多学科共识终结了一场争议。德国乳腺病学会
Strahlenther Onkol. 2001 Jan;177(1):1-9.
6
[Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].[局部区域放射治疗在术前化疗及乳房切除术后淋巴结阴性乳腺癌患者中的作用。居里研究所 - 勒内 - 于格南医院的经验]
Cancer Radiother. 2011 Dec;15(8):675-82. doi: 10.1016/j.canrad.2011.04.004. Epub 2011 Aug 9.
7
[Postmastectomy locoregional radiotherapy for breast cancer: literature review].
Cancer Radiother. 2000 Jan-Feb;4(1):3-26. doi: 10.1016/s1278-3218(00)88648-5.
8
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.DEGRO乳腺癌放疗实用指南VI：局部区域乳腺癌复发的治疗
Strahlenther Onkol. 2016 Apr;192(4):199-208. doi: 10.1007/s00066-015-0939-7. Epub 2016 Mar 1.
9
A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.切缘阳性并不总是早期乳腺癌乳房切除术后放疗的指征。
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):797-804. doi: 10.1016/S0360-3016(03)01626-2.
10
Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review.pT3N0期乳腺癌保乳术后放疗：一项回顾性多机构研究
Breast J. 2017 Jul;23(4):452-455. doi: 10.1111/tbj.12765. Epub 2017 Jan 25.
引用本文的文献
1
Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry.保乳术后局部晚期乳腺癌的大分割放疗：急性毒性和剂量测定的中期报告
Rep Pract Oncol Radiother. 2022 Dec 29;27(6):943-953. doi: 10.5603/RPOR.a2022.0102. eCollection 2022.
2
"Immediate versus delayed autologous breast reconstruction in patients undergoing post-mastectomy radiation therapy: A paradigm shift".“即刻与延迟自体乳房重建在接受乳腺癌根治术后放疗患者中的应用：观念转变”。
J Surg Oncol. 2022 Nov;126(6):949-955. doi: 10.1002/jso.27005. Epub 2022 Jul 7.
3
Conserving the axilla in breast cancer.乳腺癌腋窝的保留
Ecancermedicalscience. 2020 Aug 18;14:1090. doi: 10.3332/ecancer.2020.1090. eCollection 2020.
4
Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.乳腺癌中的鞘氨醇激酶1——一种新的分子标志物和治疗靶点
Front Oncol. 2020 Mar 20;10:289. doi: 10.3389/fonc.2020.00289. eCollection 2020.
5
Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study.女性乳腺癌患者腋窝淋巴结转移≥5枚时行术后放疗可提高生存率：一项基于人群的研究
Medicine (Baltimore). 2017 Jan;96(4):e5998. doi: 10.1097/MD.0000000000005998.
6
Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.质疑东南癌症中心前哨淋巴结阳性早期乳腺癌腋窝淋巴结清扫术的作用。
Ir J Med Sci. 2015 Mar;184(1):189-94. doi: 10.1007/s11845-014-1085-4. Epub 2014 Mar 2.
本文引用的文献
1
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.如国际共识报告所建议的，乳房切除术后放疗的益处是否仅限于有四个或更多阳性淋巴结的患者？丹麦乳腺癌协作组82 b&c随机试验的亚组分析。
Radiother Oncol. 2007 Mar;82(3):247-53. doi: 10.1016/j.radonc.2007.02.001. Epub 2007 Feb 15.
2
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.来曲唑与他莫昔芬在绝经后早期乳腺癌女性中的比较。
N Engl J Med. 2005 Dec 29;353(26):2747-57. doi: 10.1056/NEJMoa052258.
3
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.曲妥珠单抗联合辅助化疗用于可手术的HER2阳性乳腺癌
N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122.
4
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.HER2阳性乳腺癌辅助化疗后使用曲妥珠单抗。
N Engl J Med. 2005 Oct 20;353(16):1659-72. doi: 10.1056/NEJMoa052306.
5
Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.临床研究：接受乳房切除术且未接受放疗的乳腺癌患者区域淋巴结转移模式
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1508-13. doi: 10.1016/j.ijrobp.2005.05.044. Epub 2005 Sep 19.
6
Adjuvant docetaxel for node-positive breast cancer.多西他赛辅助治疗淋巴结阳性乳腺癌。
N Engl J Med. 2005 Jun 2;352(22):2302-13. doi: 10.1056/NEJMoa043681.
7
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.早期乳腺癌化疗和激素治疗对复发及15年生存率的影响：随机试验综述
Lancet. 2005;365(9472):1687-717. doi: 10.1016/S0140-6736(05)66544-0.
8
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.接受乳房切除术及辅助化疗（使用或不使用他莫昔芬且未进行放疗）治疗的可手术乳腺癌患者的局部区域复发模式：五项国家外科辅助乳腺和肠道项目随机临床试验的结果
J Clin Oncol. 2004 Nov 1;22(21):4247-54. doi: 10.1200/JCO.2004.01.042. Epub 2004 Sep 27.
9
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.他莫昔芬治疗两至三年后依西美坦用于绝经后原发性乳腺癌女性的一项随机试验。
N Engl J Med. 2004 Mar 11;350(11):1081-92. doi: 10.1056/NEJMoa040331.
10
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.阿那曲唑单药或与他莫昔芬联合应用对比他莫昔芬单药用于绝经后早期乳腺癌妇女的辅助治疗：ATAC（阿那曲唑、他莫昔芬单药或联合应用）试验疗效和安全性更新分析结果
Cancer. 2003 Nov 1;98(9):1802-10. doi: 10.1002/cncr.11745.
Zotero 插件